Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers.

Gruschwitz T, Gajda M, Enkelmann A, Grimm MO, Wunderlich H, Horstmann M, Junker K.

Int Urol Nephrol. 2014 Sep;46(9):1769-74. doi: 10.1007/s11255-014-0714-1. Epub 2014 Apr 22.

PMID:
24752865
2.

[Clinical utility of fluorescence in situ hybridization improves the sensitivity in the diagnosis of upper urinary tract urothelial carcinoma].

Mu DW, Zhou LQ, Ding Y, He ZS, Wang Y, He Q, Yang XY.

Beijing Da Xue Xue Bao Yi Xue Ban. 2010 Aug 18;42(4):381-5. Chinese.

3.

Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.

Gomella LG, Mann MJ, Cleary RC, Hubosky SG, Bagley DH, Thumar AB, McCue PA, Lallas CD, Trabulsi EJ.

Can J Urol. 2017 Feb;24(1):8620-8626.

4.

Investigating upper urinary tract urothelial carcinomas: a single-centre 10-year experience.

Dev HS, Poo S, Armitage J, Wiseman O, Shah N, Al-Hayek S.

World J Urol. 2017 Jan;35(1):131-138. doi: 10.1007/s00345-016-1820-8. Epub 2016 Apr 29.

5.

Fluorescence in situ hybridization for detecting upper urinary tract tumors--a preliminary report.

Akkad T, Brunner A, Pallwein L, Gozzi C, Bartsch G, Mikuz G, Steiner H, Verdorfer I.

Urology. 2007 Oct;70(4):753-7.

PMID:
17991550
6.

Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Kobayashi Y, Saika T, Miyaji Y, Saegusa M, Arata R, Akebi N, Takenaka T, Manabe D, Nasu Y, Kumon H.

World J Urol. 2012 Apr;30(2):271-5. doi: 10.1007/s00345-011-0731-y. Epub 2011 Jul 30.

PMID:
21805177
7.

Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.

Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M; French Collaborative National Database on U.U.T.-U.C.

BJU Int. 2012 Oct;110(8):1134-41. doi: 10.1111/j.1464-410X.2012.10960.x. Epub 2012 Mar 6.

8.

Prognostic factors in laser treatment of upper urinary tract urothelial tumours.

Niţă G, Georgescu D, Mulţescu R, Draguţescu M, Mihai B, Geavlete B, Persu C, Geavlete P.

J Med Life. 2012 Feb 22;5(1):33-8. Epub 2012 Mar 5.

9.

Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples.

Reynolds JP, Voss JS, Kipp BR, Karnes RJ, Nassar A, Clayton AC, Henry MR, Sebo TJ, Zhang J, Halling KC.

Cancer Cytopathol. 2014 Jun;122(6):459-67. doi: 10.1002/cncy.21414. Epub 2014 Mar 6.

10.

Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma.

Marín-Aguilera M, Mengual L, Ribal MJ, Musquera M, Ars E, Villavicencio H, Algaba F, Alcaraz A.

Eur Urol. 2007 Feb;51(2):409-15; discussion 415. Epub 2006 Sep 8.

PMID:
17010508
11.

Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance.

Johannes JR, Nelson E, Bibbo M, Bagley DH.

J Urol. 2010 Sep;184(3):879-82. doi: 10.1016/j.juro.2010.05.023.

PMID:
20643443
12.

Utility of fluorescence in situ hybridization analysis for detecting upper urinary tract-urothelial carcinoma.

Yu J, Xiong H, Wei C, Cui Z, Jin X, Zhang J.

J Cancer Res Ther. 2017;13(4):647-650. doi: 10.4103/jcrt.JCRT_74_17.

13.
14.

Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.

Huang WT, Li LY, Pang J, Ruan XX, Sun QP, Yang WJ, Gao X.

Neoplasma. 2012;59(4):355-60. doi: 10.4149/neo_2012_046.

PMID:
22489689
15.

Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma.

Cornu JN, Rouprêt M, Carpentier X, Geavlete B, de Medina SG, Cussenot O, Traxer O.

World J Urol. 2010 Apr;28(2):151-6. doi: 10.1007/s00345-009-0494-x. Epub 2010 Jan 1.

PMID:
20044752
16.

Primary urothelial carcinoma of the upper urinary tract in dialysis patients with 5-year follow-up.

Kang CH, Chen CH, Chiang PH.

Jpn J Clin Oncol. 2010 Mar;40(3):241-6. doi: 10.1093/jjco/hyp143. Epub 2009 Nov 22.

PMID:
19933687
17.

Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.

Luo B, Li W, Deng CH, Zheng FF, Sun XZ, Wang DH, Dai YP.

Cancer Genet Cytogenet. 2009 Mar;189(2):93-7. doi: 10.1016/j.cancergencyto.2008.10.015.

PMID:
19215789
18.

Utility of a modality combining FISH and cytology in upper tract urothelial carcinoma detection in voided urine samples of Chinese patients.

Xu C, Zeng Q, Hou J, Gao L, Zhang Z, Xu W, Yang B, Sun Y.

Urology. 2011 Mar;77(3):636-41. doi: 10.1016/j.urology.2010.07.498. Epub 2011 Jan 22.

PMID:
21256577
19.

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.

Halling KC, King W, Sokolova IA, Meyer RG, Burkhardt HM, Halling AC, Cheville JC, Sebo TJ, Ramakumar S, Stewart CS, Pankratz S, O'Kane DJ, Seelig SA, Lieber MM, Jenkins RB.

J Urol. 2000 Nov;164(5):1768-75.

PMID:
11025767
20.

[Urinary BLCA-4 level is useful to detect upper urinary tract urothelial cell carcinoma].

Feng CC, Wu Z, Jiang HW, Wen H, Guan M, Ding Q.

Actas Urol Esp. 2012 Nov-Dec;36(10):597-602. doi: 10.1016/j.acuro.2012.03.018. Epub 2012 Sep 19. Spanish.

PMID:
22998857

Supplemental Content

Support Center